HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dejuan Kong Selected Research

3,3'-diindolylmethane (diindolylmethane)

7/2013Antioxidant function of isoflavone and 3,3'-diindolylmethane: are they important for cancer prevention and therapy?
1/2012Targeting bone remodeling by isoflavone and 3,3'-diindolylmethane in the context of prostate cancer bone metastasis.
1/2012Activation of AMP-activated protein kinase by 3,3'-Diindolylmethane (DIM) is associated with human prostate cancer cell death in vitro and in vivo.
9/2011Inactivation of AR/TMPRSS2-ERG/Wnt signaling networks attenuates the aggressive behavior of prostate cancer cells.
6/2010Implication of microRNAs in drug resistance for designing novel cancer therapy.
6/2010Regulation of microRNAs by natural agents: an emerging field in chemoprevention and chemotherapy research.
11/2009Down-regulation of uPA and uPAR by 3,3'-diindolylmethane contributes to the inhibition of cell growth and migration of breast cancer cells.
11/2009Cellular signaling perturbation by natural products.
8/2009Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells.
7/20093,3'-Diindolylmethane enhances chemosensitivity of multiple chemotherapeutic agents in pancreatic cancer.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dejuan Kong Research Topics

Disease

69Neoplasms (Cancer)
10/2021 - 12/2007
22Prostatic Neoplasms (Prostate Cancer)
02/2015 - 04/2007
18Neoplasm Metastasis (Metastasis)
05/2014 - 04/2007
17Pancreatic Neoplasms (Pancreatic Cancer)
08/2014 - 09/2007
10Breast Neoplasms (Breast Cancer)
01/2016 - 12/2008
5Inflammation (Inflammations)
08/2021 - 12/2009
4Carcinogenesis
01/2014 - 03/2008
4Hypoxia (Hypoxemia)
12/2012 - 01/2012
3Ovarian Neoplasms (Ovarian Cancer)
10/2021 - 12/2012
3Pathologic Processes
12/2013 - 08/2009
2Necrosis
03/2013 - 06/2012
2Chronic Disease (Chronic Diseases)
04/2011 - 12/2009
1Ganglion Cysts (Ganglion)
01/2022
1Leukemia
10/2021
1Reperfusion Injury
08/2021
1Ischemia
08/2021
1Retinal Detachment (Retinal Detachments)
01/2021
1Multiple Myeloma
11/2018
17 Hereditary Prostate Cancer
02/2015
1Ataxia Telangiectasia (Louis Bar Syndrome)
09/2014
1Chromosomal Instability (Chromosome Stability)
09/2014
1Genomic Instability
01/2014
1Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2013
1Carcinoma (Carcinomatosis)
06/2012
1Diabetes Mellitus
03/2012

Drug/Important Bio-Agent (IBA)

26MicroRNAs (MicroRNA)IBA
09/2014 - 08/2009
16Biological ProductsIBA
09/2013 - 03/2008
16NF-kappa B (NF-kB)IBA
07/2013 - 04/2007
15IsoflavonesIBA
10/2013 - 10/2008
143,3'-diindolylmethane (diindolylmethane)IBA
07/2013 - 04/2007
10Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2012 - 04/2007
8Pharmaceutical PreparationsIBA
10/2021 - 07/2009
8Androgen Receptors (Androgen Receptor)IBA
02/2015 - 07/2007
8Transcription Factors (Transcription Factor)IBA
12/2012 - 09/2007
8CurcuminIBA
10/2012 - 08/2008
6Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2008
5Platelet-Derived Growth FactorIBA
01/2016 - 12/2007
5GenisteinIBA
01/2014 - 10/2008
5DNA (Deoxyribonucleic Acid)IBA
01/2014 - 04/2007
5GemcitabineFDA Link
03/2012 - 03/2009
4AndrogensIBA
02/2015 - 07/2007
4Small Interfering RNA (siRNA)IBA
02/2015 - 12/2007
4Epithelial Cell Adhesion MoleculeIBA
08/2014 - 08/2011
4garcinolIBA
12/2012 - 04/2010
3AntioxidantsIBA
01/2014 - 01/2012
3indole-3-carbinolIBA
01/2012 - 11/2009
3Hormones (Hormone)IBA
10/2011 - 07/2007
3Complementary DNA (cDNA)IBA
07/2010 - 12/2007
3SurvivinIBA
06/2010 - 05/2009
3Matrix Metalloproteinases (MMPs)IBA
06/2009 - 04/2007
2Vincristine (Oncovin)FDA LinkGeneric
08/2016 - 06/2012
2Phosphotransferases (Kinase)IBA
09/2014 - 02/2010
2indoleIBA
09/2013 - 08/2010
2TOR Serine-Threonine KinasesIBA
09/2013 - 01/2012
2monodansylcadaverineIBA
03/2013 - 06/2012
2Propidium (Propidium Iodide)IBA
03/2013 - 06/2012
2Cisplatin (Platino)FDA LinkGeneric
06/2012 - 07/2009
2Metformin (Glucophage)FDA LinkGeneric
03/2012 - 04/2011
2Interleukin-6 (Interleukin 6)IBA
01/2012 - 01/2012
2Antineoplastic Agents (Antineoplastics)IBA
07/2011 - 02/2010
2Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2011 - 07/2009
2Biomarkers (Surrogate Marker)IBA
06/2010 - 06/2010
2ResveratrolIBA
06/2010 - 11/2009
2LigandsIBA
03/2010 - 03/2009
2Jagged-1 ProteinIBA
03/2010 - 03/2009
2Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
11/2009 - 04/2007
2Urokinase Plasminogen Activator ReceptorsIBA
11/2009 - 06/2009
2Glycogen Synthase Kinase 3 betaIBA
10/2008 - 07/2007
1Mechanistic Target of Rapamycin Complex 1IBA
01/2022
1Sirolimus (Rapamycin)FDA Link
01/2022
1Retinaldehyde (Retinal)IBA
08/2021
1Tetracycline (Achromycin)FDA LinkGeneric
08/2021
1Minocycline (Cyclops)FDA LinkGeneric
08/2021
1HMGB1 Protein (HMG1)IBA
01/2021
1Bortezomib (Velcade)FDA Link
11/2018
1Annexin A1IBA
11/2018
1Serine (L-Serine)FDA Link
09/2014
1SugarsIBA
01/2014
1LipidsIBA
01/2014
1Mitogen-Activated Protein Kinase 14IBA
12/2013
1daidzeinIBA
10/2013
1biochanin AIBA
10/2013
1EquolIBA
10/2013
1Phosphatidylinositols (Phosphatidylinositol)IBA
09/2013
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
09/2013
1DAPIIBA
03/2013
1ParaffinIBA
01/2013
1Formaldehyde (Formol)FDA Link
01/2013
1Messenger RNA (mRNA)IBA
06/2012
1bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA
06/2012
1Etoposide (VP 16)FDA LinkGeneric
06/2012
1pirarubicinIBA
06/2012
1ZincIBA
04/2012

Therapy/Procedure

31Therapeutics
02/2015 - 01/2008
9Drug Therapy (Chemotherapy)
10/2021 - 07/2009
8Radiotherapy
10/2021 - 04/2010
3Chemoprevention
07/2013 - 05/2009
1Castration
02/2015
1Chinese Traditional Medicine (Traditional Chinese Medicine)
05/2013
1Oral Administration
03/2012